97 related articles for article (PubMed ID: 5401365)
1. [Immunogenic activity of the regional lymphoreticulum during primary cancer of the lung].
Lenzini L; Barnabé R
Folia Allergol (Roma); 1969; 16(6):524-34. PubMed ID: 5401365
[No Abstract] [Full Text] [Related]
2. [Clinical features and inhibitory activity of regional lymph node cells on the cytotoxicity of autologous killer cells in patients with primary lung cancer].
Kadoyama C; Kimura H; Yamaguchi Y
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2906-11. PubMed ID: 2959205
[TBL] [Abstract][Full Text] [Related]
3. Bronchial carcinoma and its regional lymph nodes in relation to immunological functions.
Syrjänen KJ
Z Immunitatsforsch Immunobiol; 1979 Feb; 155(3):212-22. PubMed ID: 311556
[TBL] [Abstract][Full Text] [Related]
4. [Immunomorphology of lymph nodes and prognosis in lung cancer].
Di Giorgio A; Sammartino P; Canavese A; Arnone P; Sibio S; Accarpio F; Al Mansour M
Minerva Chir; 2001 Apr; 56(2):153-9. PubMed ID: 11353348
[TBL] [Abstract][Full Text] [Related]
5. [Activated cells in the peripheral blood in lung cancer].
Qian L
Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):18-21, 62. PubMed ID: 2848634
[No Abstract] [Full Text] [Related]
6. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
[TBL] [Abstract][Full Text] [Related]
7. [Immunologic status in lung cancer].
Briusov PG; Polovoĭ AM
Sov Med; 1983; (3):16-9. PubMed ID: 6857368
[No Abstract] [Full Text] [Related]
8. [Serum concentration of C3 in primary lung cancer patients].
Bariffi F; Marsico SA; Vigorito C; Alfani G; Donato Di Paola RM
Arch Monaldi; 1980; 35(4):169-74. PubMed ID: 6282231
[No Abstract] [Full Text] [Related]
9. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
[TBL] [Abstract][Full Text] [Related]
10. Lung carcinoma: analysis of T helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry.
Ito N; Nakamura H; Tanaka Y; Ohgi S
Cancer; 1999 Jun; 85(11):2359-67. PubMed ID: 10357406
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood lymphocytes and their subpopulations in lung carcinoma.
Zółtowska A; Skokowski J; Mlekodaj S; Boj E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):649-53. PubMed ID: 6970027
[TBL] [Abstract][Full Text] [Related]
12. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
Grah J; Samija M; Juretić A; Sarcević B; Sobat H
Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
[TBL] [Abstract][Full Text] [Related]
13. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
[TBL] [Abstract][Full Text] [Related]
14. [Immunomorphologic responses of regional lymph nodes and prognosis in patients with stage Ia pulmonary adenocarcinoma].
Takakura H; Hirohasi S; Shimosato Y; Kodama T; Kameya T; Naruke T; Suemasu K
Gan No Rinsho; 1983 Jun; 29(7):777-84. PubMed ID: 6876444
[TBL] [Abstract][Full Text] [Related]
15. [Immunological aspects of lung cancer].
Miquel Muse I; Klempert H; Mazzara R; Rodrĩguez Villamil J; Allo G; Korc I
Torax; 1970 Dec; 19(4):222-31. PubMed ID: 5520152
[No Abstract] [Full Text] [Related]
16. Immunohistochemical study with monoclonal antibodies on immune response in human lung cancers.
Watanabe S; Sato Y; Kodama T; Shimosato Y
Cancer Res; 1983 Dec; 43(12 Pt 1):5883-9. PubMed ID: 6605803
[TBL] [Abstract][Full Text] [Related]
17. [Phagocytic activity in various lung tumors].
Mikhova Ts; Uzunov P; Vlasov V; Vodenicharova S
Eksp Med Morfol; 1988; 27(3):39-43. PubMed ID: 2851435
[No Abstract] [Full Text] [Related]
18. The activity of neutrophil myeloperoxidase in patients with lung carcinoma.
Dabrowska M; Prokopowicz J; Pietruczuk M; Kemona H; Wołosowicz N; Kiluk S; Głuszczak M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):613-9. PubMed ID: 2465241
[TBL] [Abstract][Full Text] [Related]
19. [Identification of T lymphocytes in resected lung tissue in primary bronchial cancer].
Grubek-Jaworska H; Olechnowicz H; Szymańska
Pneumonol Pol; 1984 Mar; 52(3):105-10. PubMed ID: 6610173
[No Abstract] [Full Text] [Related]
20. HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating lymphocytes of patients with non-small cell lung cancer.
Seki N; Hoshino T; Kikuchi M; Hayashi A; Itoh K
Cell Immunol; 1997 Feb; 175(2):101-10. PubMed ID: 9023415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
